This research explores how quantum computing could revolutionize genomics, with a focus on how it could speed up DNA analysis and advance uses of artificial intelligence (AI) in genomics. This study’s primary objective is to investigate recent review articles and existing research results in order to demonstrate the tremendous effects that quantum computing may have on genomics.DNA analysis is expected to undergo a radical change as a result of quantum computing, which promises to revolutionize the field by substantially reducing processing times and resource needs. Additionally, it opens up fresh possibilities for improving AI methods used with genomics data. Quantum computing ushers in a paradigm shift in genomics research, enabling AI-driven drug discovery and customized medicine in addition to accelerating DNA sequencing and assembly.By addressing the significant difficulties brought on by the rapid expansion of genetic data and the requirement for more effective and scalable computational approaches, this publication emphasizes the significance of this study. The integration of quantum computing with genomics also raises ethical and security concerns, underscoring the significance of responsible research and use in this transformative era.In conclusion, this article highlights the potential of quantum computing to change genomics, delivering faster and more precise ways of analysis that will unquestionably have significant repercussions for healthcare, biotechnology, and scientific research. It emphasizes how important it is to keep up with the most recent advancements in this quickly changing area.
This research explores how quantum computing could revolutionize genomics, with a focus on how it could speed up DNA analysis and advance uses of artificial intelligence (AI) in genomics. This study’s primary objective is to investigate recent review articles and existing research results in order to demonstrate the tremendous effects that quantum computing may have on genomics.DNA analysis is expected to undergo a radical change as a result of quantum computing, which promises to revolutionize the field by substantially reducing processing times and resource needs. Additionally, it opens up fresh possibilities for improving AI methods used with genomics data. Quantum computing ushers in a paradigm shift in genomics research, enabling AI-driven drug discovery and customized medicine in addition to accelerating DNA sequencing and assembly.By addressing the significant difficulties brought on by the rapid expansion of genetic data and the requirement for more effective and scalable computational approaches, this publication emphasizes the significance of this study. The integration of quantum computing with genomics also raises ethical and security concerns, underscoring the significance of responsible research and use in this transformative era.In conclusion, this article highlights the potential of quantum computing to change genomics, delivering faster and more precise ways of analysis that will unquestionably have significant repercussions for healthcare, biotechnology, and scientific research. It emphasizes how important it is to keep up with the most recent advancements in this quickly changing area.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI\\\'s predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning's role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug- receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual\\\'s genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions.
The use of quantum computing1 in healthcare represents a significant shift with the potential to revolutionize medical research, diagnostics, and treatment. Quantum computing can process and analyze large datasets much faster than classical computing, offering new opportunities in healthcare. This paper examines the various ways quantum computing can be applied in healthcare, such as in drug discovery, genetic research, personalized medicine, and complex disease modeling. By using quantum algorithms, researchers can identify new treatment targets and simulate the effects of drugs on human biology in ways that were previously impossible, which can reduce the time and cost of bringing new drugs to market. Quantum computing also allows for analyzing large genomic datasets2, which can help tailor treatments to individual genetic profiles. Additionally, this technology helps in modeling complex biological systems and disease processes, providing insights into the mechanisms of diseases at a molecular level and enabling the development of more effective treatments. However, integrating quantum computing into healthcare comes with challenges such as technical limitations, the need for specialized expertise, data security concerns, and ethical considerations. This paper provides a comprehensive overview of the potential applications of quantum computing in healthcare, addresses the associated challenges, and discusses the future directions of this growing field, emphasizing the importance of interdisciplinary collaboration in fully utilizing quantum technologies in medicine. In recent years, quantum computing has rapidly advanced and attracted significant interest from academia and industry due to its unique ability to process information differently, resulting in previously unattainable computational capabilities. Despite its potential, the full impact of quantum computing on healthcare has not been thoroughly explored. This survey paper provides a systematic analysis of quantum computing's various capabilities in improving healthcare systems, focusing on its potential to transform compute-intensive healthcare tasks such as drug discovery, personalized medicine, DNA sequencing4, medical imaging5, and operational optimization. Through a comprehensive review of existing literature, we have developed taxonomies6 covering different aspects, including background and enabling technologies, applications, requirements, architectures, security, open issues, and future research directions, offering a comprehensive view of the quantum computing paradigm for healthcare. Our survey aims to assist new and experienced researchers in quantum computing and healthcare by helping them comprehend the current research landscape, identify potential opportunities and challenges, and make informed decisions when developing new architectures and applications for quantum computing in healthcare
Abstract Quantum computing and artificial intelligence (AI) are converging to reshape the future of healthcare. Modern medicine generates vast and complex datasets from imaging, genomics, wearable sensors, and real-time clinical records. While AI has already demonstrated significant potential in diagnostics, drug discovery, and personalised medicine, its progress is often constrained by high computational demand, limited interpretability, and energy inefficiency. Quantum computing offers a fundamentally different paradigm, using qubits, superposition, and entanglement to process high-dimensional data and explore solution spaces in parallel. This synergy-quantum-enhanced AI or quantum machine learning (QML)promises transformative capabilities across the healthcare continuum. This narrative review explores the foundations of quantum computing, the evolution of AI in medicine, and the points where these technologies intersect. Applications span a range of biomedical domains. In radiology and pathology, quantum-assisted classifiers can enhance both the speed and interpretability of image analysis. In drug discovery and genomics, variational quantum eigensolvers and hybrid quantum–classical models may accelerate molecular simulations and genome-wide association studies. In personalized medicine, quantum kernel methods enable more precise phenotype clustering and improve the accuracy of treatment response predictions. Operationally, quantum-AI integration also supports hospital logistics, ICU resource allocation, and supply-chain resilience. Despite these opportunities, significant challenges remain, including hardware limitations, data encoding bottlenecks, interpretability deficits, and regulatory ambiguity. Ethical concerns around privacy, equity, and compliance with frameworks such as HIPAA and GDPR must also be addressed. By mapping opportunities and risks, this review underscores that quantum-AI is no longer speculative but an emerging reality. Harnessing its potential requires multidisciplinary collaboration to translate qubits and algorithms into tangible improvements in patient outcomes, clinical trust, and system efficiency.
Due to its capacity to handle information in fundamentally new ways, leading to computational powers that were previously unreachable, the multidisciplinary subject of quantum computing has recently grown and attracted significant interest from both academia and industry. Quantum computing has great promise, but how exactly it will change healthcare is still largely unknown. The potential of quantum computing to transform compute-intensive healthcare tasks like drug discovery, personalized medicine, DNA sequencing, medical imaging, and operational optimization is the primary focus of this survey paper, which offers the first comprehensive analysis of quantum computing's diverse capabilities in improving healthcare systems. A new era in healthcare is on the horizon, thanks to quantum computing and AI coming together to transform complicated biological simulations, the processing of genetic data, and advances in drug development. Biological data may be extremely large and complicated, making it difficult for traditional computing tools to handle. This slows down and impairs the accuracy of medical discoveries. Combining the predictive power of AI with the exponential processing speed of quantum computers presents a game-changing opportunity to speed up biological research and clinical applications. The function of quantum machine learning in improving drug discovery molecular dynamics simulations powered by artificial intelligence is discussed in this article. Quickly modeling chemical interactions, analyzing drug-receptor binding affinities, and predicting pharmacokinetics with extraordinary precision are all possible with quantum-enhanced algorithms. To further improve disease progression prediction and therapeutic target identification, we also investigate quantum-assisted deep learning models for understanding complex biological processes like protein folding, epigenetic changes, and connections between metabolic pathways.
By facilitating quicker and more precise analysis of intricate biological data, the union of quantum computing and Artificial Intelligence (AI) may transform genomic medicine and drug discovery altogether. The study suggests a model for artificial intelligence with quantum-enhanced acceleration based on hybrid quantum-classical models in order to speed up drug discovery and customize therapies. It utilizes deep learning models and Quantum Machine Learning (QML) techniques to analyze patient-specific data, protein structures, and genetic sequences. Large genomic and clinical data sets are processed by conventional deep learning models, while the quantum component carries out efficient data encoding and optimization processes. As compared to other traditional AI-based approaches, the proposed model performs a 30% improved drug target identification when evaluated against more than 1,000 genetic sequences and related clinical outcomes. The hybrid model was as accurate as 98.4% in its prediction and was more accurate than the conventional AI techniques including random forests (accuracy: 91.3%) and gradient boosting machines (accuracy: 93.7%). The methodology also produced an F1-score of 0.95 with accuracy and recall scores of 96.1% and 94.7%, respectively. These results demonstrate how quantum-enhanced AI can reduce the time for computation and improve the accuracy of genomic data analysis, driving significant progress toward personalized therapy and drug development.